Testing EMONO gas plus antidepressants for depression in dementia
Part of Mental health clinical trials.
This study tests whether adding a special gas (EMONO, also called laughing gas) to regular antidepressants can help improve depression symptoms in nursing home residents with dementia. It is a potential extra treatment option for people who still feel depressed despite taking medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older and live in a nursing home
- You have been diagnosed with dementia (major neurocognitive disorder) for at least 6 months
- You have depression symptoms that are noticeable and scored by a doctor
- You do not have severe agitation or unstable heart/brain conditions
- You have not used the study gas (EMONO/MEOPA) in the past 6 months
- Your vitamin B12 and B9 levels are normal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how nitrous oxide (laughing gas) affects your emotions and thinking. It's looking for healthy volunteers ages 18 to 40 to see how the gas might change emotional processing.
This Phase 1 study tests whether breathing nitrous oxide can safely reduce suicidal thoughts in adults with major depression. It may help people whose depression is causing moderate to severe suicidal thinking, by studying a fast-acting treatment approach.
This trial tests whether a medication used for Parkinson's disease (carbidopa-levodopa) can help people with major depression who have lost interest or pleasure in things. It is for adults who have not been helped enough by other treatments and have signs of inflammation.
This trial studies how depression and antidepressants affect belief updating in older adults. You may join if you are over 65, have major depression, and are starting a new antidepressant. The goal is to learn more about how your brain adjusts beliefs over time.
This study tests if laughing gas (nitrous oxide) can safely improve mood in adults with depression who haven't gotten better after trying two antidepressant medicines. It may offer a new option for treatment-resistant depression.
This early study tests whether nitrous oxide, aimed at specific brain circuits, can change depression-related brain activity. It is mainly for adults with major depression or treatment-resistant depression, and includes brain imaging during the study.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.